Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model

Overview

Journal J Clin Med

Specialty General Medicine

Date 2021 Jun 2

PMID 34065216

Citations 4

Authors

Jesus Funuyet-Salas

Agustin Martin-Rodriguez

Maria Angeles Perez-San-Gregorio

Manuel Romero-Gomez

Affiliations

Soon will be listed here.

Abstract

Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and adherence to physical activity in patients with non-alcoholic fatty liver disease (NAFLD), as well as the association between social support and adherence to diet. We also examined whether self-efficacy exerted a moderating role in these associations. QoL (SF-12), social support (MSPSS), depressive symptoms (HADS), self-efficacy (GSE), physical activity (IPAQ) and diet (MEDAS) were evaluated in 413 biopsy-proven NAFLD patients. Mediation and moderated mediation models were conducted using the SPSS PROCESS v3.5 macro. Results showed that depressive symptoms mediated the relationship between physical QoL and adherence to physical activity (indirect effect = 6.248, CI = 1.917-10.727), as well as the relationship between social support and adherence to diet (indirect effect = 0.148, CI = 0.035-0.275). Self-efficacy also moderated the indirect effects of QoL and social support on therapeutic adherence through depressive symptoms. Specifically, the higher self-efficacy was, the lower the negative impact on the NAFLD patient's mental health. In conclusion, self-efficacy is defined as a protective factor for therapeutic adherence by NAFLD patients with a psychosocial risk profile. Self-efficacy should, therefore, be a main psychological target in future multidisciplinary NAFLD approaches.

Citing Articles

Health and Liver Diagnostic Markers Influencing Glycemia in Subjects with Prediabetes: Preview Study.

Ramos-Lopez O, Martinez-Urbistondo D, Navas-Carretero S, Zhu R, Huttunen-Lenz M, Stratton G Diagnostics (Basel). 2025; 14(24.

PMID: 39767255 PMC: 11675722. DOI: 10.3390/diagnostics14242895.

Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study.

Huang R, Fan J, Shi J, Mao Y, Wang B, Zhao J BMJ Open. 2023; 13(6):e062131.

PMID: 37339833 PMC: 10314458. DOI: 10.1136/bmjopen-2022-062131.

Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease.

Holmes R, Patel A, Desai A Clin Liver Dis (Hoboken). 2022; 20(2):32-37.

PMID: 36033426 PMC: 9405520. DOI: 10.1002/cld.1204.

Non-alcoholic Fatty Liver Disease and Depression: Evidence for Genotype × Environment Interaction in Mexican Americans.

Manusov E, Diego V, Sheikh K, Laston S, Blangero J, Williams-Blangero S Front Psychiatry. 2022; 13:936052.

PMID: 35845438 PMC: 9283683. DOI: 10.3389/fpsyt.2022.936052.

Shuxie-1 Decoction Alleviated CUMS -Induced Liver Injury via IL-6/JAK2/STAT3 Signaling.

Zhang M, Wu W, Huang C, Cai T, Zhao N, Liu S Front Pharmacol. 2022; 13:848355.

PMID: 35462928 PMC: 9019685. DOI: 10.3389/fphar.2022.848355.

References

Naicker K, Overland S, Johnson J, Manuel D, Skogen J, Sivertsen B . Symptoms of anxiety and depression in type 2 diabetes: Associations with clinical diabetes measures and self-management outcomes in the Norwegian HUNT study. Psychoneuroendocrinology. 2017; 84:116-123. DOI: 10.1016/j.psyneuen.2017.07.002. View

Somerset S, Graham L, Markwell K . Depression scores predict adherence in a dietary weight loss intervention trial. Clin Nutr. 2011; 30(5):593-8. DOI: 10.1016/j.clnu.2011.04.004. View

. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016; 64(6):1388-402. DOI: 10.1016/j.jhep.2015.11.004. View

Craig C, Marshall A, Sjostrom M, Bauman A, Booth M, Ainsworth B . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003; 35(8):1381-95. DOI: 10.1249/01.MSS.0000078924.61453.FB. View

Romero-Gomez M, Zelber-Sagi S, Trenell M . Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017; 67(4):829-846. DOI: 10.1016/j.jhep.2017.05.016. View

Bellentani S, Dalle Grave R, Suppini A, Marchesini G . Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology. 2007; 47(2):746-54. DOI: 10.1002/hep.22009. View

Karfopoulou E, Anastasiou C, Avgeraki E, Kosmidis M, Yannakoulia M . The role of social support in weight loss maintenance: results from the MedWeight study. J Behav Med. 2016; 39(3):511-8. DOI: 10.1007/s10865-016-9717-y. View

Aggarwal B, Liao M, Allegrante J, Mosca L . Low social support level is associated with non-adherence to diet at 1 year in the Family Intervention Trial for Heart Health (FIT Heart). J Nutr Educ Behav. 2010; 42(6):380-8. PMC: 2978807. DOI: 10.1016/j.jneb.2009.08.006. View

Lotfi A, Saneei P, Hekmatdost A, Salehisahlabadi A, Shiranian A, Ghiasvand R . The relationship between dietary antioxidant intake and physical activity rate with nonalcoholic fatty liver disease (NAFLD): A case - Control study. Clin Nutr ESPEN. 2019; 34:45-49. DOI: 10.1016/j.clnesp.2019.09.004. View

10.

Fabricatore A . Behavior therapy and cognitive-behavioral therapy of obesity: is there a difference?. J Am Diet Assoc. 2007; 107(1):92-9. DOI: 10.1016/j.jada.2006.10.005. View

11.

Serfaty L . Management of patients with non-alcoholic steatohepatitis (NASH) in real life. Liver Int. 2018; 38 Suppl 1:52-55. DOI: 10.1111/liv.13637. View

12.

Huang X, Liu X, Yu Y . Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?. Front Mol Neurosci. 2017; 10:134. PMC: 5420567. DOI: 10.3389/fnmol.2017.00134. View

13.

Hayes A, Rockwood N . Regression-based statistical mediation and moderation analysis in clinical research: Observations, recommendations, and implementation. Behav Res Ther. 2016; 98:39-57. DOI: 10.1016/j.brat.2016.11.001. View

14.

Aller R, Burgueno Gomez B, Siguenza R, Fernandez-Rodriguez C, Fernandez N, Antolin B . Comparative study of overweight and obese patients with nonalcoholic fatty liver disease. Rev Esp Enferm Dig. 2019; 111(4):256-263. DOI: 10.17235/reed.2019.5926/2018. View

15.

Centis E, Moscatiello S, Bugianesi E, Bellentani S, Fracanzani A, Calugi S . Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease. J Hepatol. 2012; 58(4):771-7. DOI: 10.1016/j.jhep.2012.11.031. View

16.

Franco I, Bianco A, Mirizzi A, Campanella A, Bonfiglio C, Sorino P . Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial. Nutrients. 2020; 13(1). PMC: 7823843. DOI: 10.3390/nu13010066. View

17.

Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

18.

Bandura A . Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84(2):191-215. DOI: 10.1037//0033-295x.84.2.191. View

19.

Barberia A, Attree M, Todd C . Understanding eating behaviours in Spanish women enrolled in a weight-loss treatment. J Clin Nurs. 2008; 17(7):957-66. DOI: 10.1111/j.1365-2702.2007.02073.x. View

20.

Gerber L, Weinstein A, Pawloski L . Role of exercise in optimizing the functional status of patients with nonalcoholic fatty liver disease. Clin Liver Dis. 2013; 18(1):113-27. DOI: 10.1016/j.cld.2013.09.016. View